-
1
-
-
0034924586
-
Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation
-
Jul.
-
Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 2001 Jul.;29(7. Suppl.):S90-4. 29, S90-S94.
-
(2001)
Crit Care Med
, vol.29
, Issue.7 SUPPL.
-
-
Levi, M.1
De Jonge, E.2
Van Der Poll, T.3
-
2
-
-
0033584457
-
Disseminated intravascular coagulation
-
Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
-
(1999)
N Engl J Med
, vol.341
, pp. 586-592
-
-
Levi, M.1
Ten Cate, H.2
-
3
-
-
0035826096
-
Efficacy and safety of recombinant human activated protein C for severe sepsis
-
Mar. 8. 344, 699-709
-
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 Mar. 8.;344(10.):699-709.344, 699-709.
-
(2001)
N Engl J Med
, vol.344
, Issue.10
, pp. 699-709
-
-
Bernard, G.R.1
Vincent, J.L.2
Laterre, P.F.3
LaRosa, S.P.4
Dhainaut, J.F.5
Lopez-Rodriguez, A.6
Steingrub, J.S.7
Garber, G.E.8
Helterbrand, J.D.9
Ely, E.W.10
Fisher, C.J.J.11
-
4
-
-
0035904368
-
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial
-
Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler, A., Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, and Opal SM. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001;286:1869-78.
-
(2001)
JAMA
, vol.286
, pp. 1869-1878
-
-
Warren, B.L.1
Eid, A.2
Singer, P.3
Pillay, S.S.4
Carl, P.5
Novak, I.6
Chalupa, P.7
Atherstone, A.8
Penzes, I.9
Kubler, A.10
Knaub, S.11
Keinecke, H.O.12
Heinrichs, H.13
Schindel, F.14
Juers, M.15
Bone, R.C.16
Opal, S.M.17
-
5
-
-
0038690407
-
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: A randomized controlled trial
-
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA . Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003;290:238-47.
-
(2003)
JAMA
, vol.290
, pp. 238-247
-
-
Abraham, E.1
Reinhart, K.2
Opal, S.3
Demeyer, I.4
Doig, C.5
Rodriguez, A.L.6
Beale, R.7
Svoboda, P.8
Laterre, P.F.9
Simon, S.10
Light, B.11
Spapen, H.12
Stone, J.13
Seibert, A.14
Peckelsen, C.15
De Deyne, C.16
Postier, R.17
Pettila, V.18
Artigas, A.19
Percell, S.R.20
Shu, V.21
Zwingelstein, C.22
Tobias, J.23
Poole, L.24
Stolzenbach, J.C.25
Creasey, A.A.26
more..
-
6
-
-
0037389094
-
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
-
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
-
(2003)
Crit Care Med
, vol.31
, pp. 1250-1256
-
-
Levy, M.M.1
Fink, M.P.2
Marshall, J.C.3
Abraham, E.4
Angus, D.5
Cook, D.6
Cohen, J.7
Opal, S.M.8
Vincent, J.L.9
Ramsay, G.10
-
7
-
-
0035160476
-
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation
-
Nov.
-
Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001 Nov.;86(5.):1327-30.
-
(2001)
Thromb Haemost
, vol.86
, Issue.5
, pp. 1327-30
-
-
Taylor, F.B.J.1
Toh, C.H.2
Hoots, W.K.3
Wada, H.4
Levi, M.5
|